Quantcast

Latest Sanofi Stories

2014-09-17 08:28:38

DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Breast Cancer Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer and...

2014-09-15 16:24:53

Winners Announced September 12th at New Products & Technology Awards Event in San Francisco ATLANTA, Sept. 15, 2014 /PRNewswire/ -- Aventis Systems, Inc., a leading provider of both new and refurbished technology equipment, was awarded with a Bronze Stevie® Award in the Executive of the Year division and another Bronze Stevie® Award in the Website division for the Computer Hardware Industry, at the 12(th )Annual American Business Awards Friday night at the Palace Hotel in San...

2014-09-10 12:28:37

Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and treatment MONTREAL, Sept. 10, 2014 /CNW Telbec/ - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today its $2.5 million contribution to co-fund the Canadian Consortium on Neurodegeneration in Aging (CCNA), a partnership officially launched in Montreal today in the presence of The Honourable Rona Ambrose, Minister of Health. With the...

2014-09-03 12:29:59

TORONTO, Sept. 3, 2014 /CNW/ - Keeping children with diabetes safe, healthy and fully involved in school activities is the goal of the following initiatives being announced today by the International Diabetes Federation (IDF) and the Canadian Diabetes Association (CDA) in Toronto: -- The North American launch of the global Kids and Diabetes in Schools (KiDS) project and information pack offering resources to teachers, children and parents...

2014-09-02 08:30:38

SAN CARLOS, Calif., Sept. 2, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has entered into an Exclusive Channel Collaboration (ECC) with Sanofi Chimie, a wholly owned subsidiary of Sanofi (EURONEXT: SAN and NYSE: SNY) to develop an enhanced production process for a specific family of its marketed Active Pharmaceutical Ingredients (APIs) through Sanofi's current manufacturing operations in France. This collaboration will...

2014-08-31 04:21:07

Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in the ODYSSEY LONG TERM trial TARRYTOWN, New York and PARIS, Aug. 31, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced detailed positive results from four Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia.(...

2014-08-31 04:20:55

- Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in ODYSSEY LONG TERM trial - PARIS and TARRYTOWN, N.Y., Aug. 31, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed positive results from four Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia....

2014-08-25 00:20:19

TARRYTOWN, N.Y. and PARIS, Aug. 25, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting. The data will also be highlighted in the official ESC press conference on August 31, at 09:00 CET / 03:00...

2014-08-24 23:00:38

LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Fexofenadine HCl Industry, 2009-2019” to its store. Inquire before buying this report at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=9591. Dallas, TX (PRWEB) August 24, 2014 This is a professional and in-depth market survey on Global and Chinese Fexofenadine HCl industry. The report firstly reviews the basic information of Fexofenadine HCl including its...

2014-08-18 23:04:31

Globally, hyaluronic acid viscosupplementation products must rely on clinical efficacy, as healthcare practitioners are not particularly responsive to branding or purchasing incentives, according to iData Research's Sports Medicine Survey. Vancouver, BC (PRWEB) August 18, 2014 According to a sports medicine survey conducted by iData Research (http://www.idataresearch.com) at the American Academy of Orthopaedic Surgeons (AAOS) conference, healthcare practitioners from around the world...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related